Drug intelligence / Profile preview

cetraria islandica

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Cetraria islandica is a lichen native to northern and alpine regions of Europe, traditionally known as Iceland moss. It is composed primarily of polysaccharides (lichenan, isolichenan), lichen acids (protolichesterinic, fumarprotocetraric, protocetraric), and usnic acid. The main medicinal uses are for the relief of respiratory (cough, bronchitis, sore throat, hoarseness) and digestive disorders (indigestion, loss of appetite, dyspepsia, mild gastrointestinal irritation). Additional uses include treatment of mouth and throat irritation, temporary appetite loss, and topical application for wounds and boils. Mechanistically, attributed actions are immunomodulatory (promoting anti-inflammatory cytokine IL-10), demulcent (soothing to mucous membranes), mild antimicrobial (notably against certain Gram-positive bacteria and Helicobacter pylori), and antioxidant effects. Its main route of use is oral (teas, extracts, lozenges, syrups), with some topical formulations. It is not a conventional pharmaceutical but rather a traditional herbal medicinal product, and is commonly available as a dietary supplement.[1][2][3][4][5][6][7][8]

Brand names
Iceland moss
Other names
Iceland lichenLichen islandicusIcelandic lichen
02

Targets

PGN (Peptidoglycan)PRR (Pattern recognition receptors)

Beyond the preview

Go deeper on cetraria islandica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cetraria islandica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call